AstraZeneca’s pause of its COVID-19 vaccine trial is a “wake-up call” demonstrating the challenges of the development process, according to the World Health Organization’s chief scientist.<
Two UK biotechs – Destiny Pharma and Sporegen – have joined forces to develop a nasal spray that they say could serve as a first line of defense against COVID-19 infections.
AstraZeneca’s decision to halt all its phase 3 trials of COVID-19 vaccine AZD1222 after an adverse reaction in a single UK volunteer may end up just being a precautionary measure, but could
It’s a bleak day in the fight against COVID-19, after the UK banned social gatherings of more than six people to contain growing numbers of new cases and the lead vaccine trial from AstraZe
As readouts for crucial late-stage coronavirus vaccine trials approach in the coming weeks and months, the FDA's chief Stephen Hahn is moving to assuage fears that its decision-making will
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.